Key Market Indicators
Sweden's insulin imports are projected to decline to approximately $75 million by 2028, down from $77 million in 2023. This represents an average annual decrease of 0.7%. Since 1997, the country's demand for insulin has fallen by around 1% each year. In stark contrast, Swedish insulin exports saw a significant drop. In 2018, exports were valued at about $131,000, plummeting from $1.2 million in 2017, marking an 89% decrease compared to the previous year. Despite this sharp decline, the broader trend since 1997 shows Swedish insulin supply has increased by over 59% annually.
